Technical Analysis for BDX - Becton, Dickinson and Company

Grade Last Price % Change Price Change
grade B 248.31 -2.69% -6.87
BDX closed down 2.69 percent on Friday, August 23, 2019, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical BDX trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Multiple of Ten Bearish Other 0.00%
Overbought Stochastic Strength 0.00%
Pocket Pivot Bullish Swing Setup -2.69%
Gapped Up Strength -2.69%
Overbought Stochastic Strength -2.69%
Crossed Above 20 DMA Bullish -2.00%
MACD Bullish Centerline Cross Bullish -2.00%

Older signals for BDX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. This segment's products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment's products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company's BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment's products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Medicine Biotechnology Biology Pharmaceutical Industry Infectious Diseases Diabetes Antibodies Cancers New Jersey Medical Technology Catheters Medical Tests Medical Devices Drug Delivery Healthcare Associated Infections Treatment Of Diabetes Healthcare Institutions Drug Delivery Systems Laboratory Products Syringe Becton Clinical Tools
Is BDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 265.87
52 Week Low 208.62
Average Volume 1,032,229
200-Day Moving Average 241.5422
50-Day Moving Average 249.9116
20-Day Moving Average 249.7625
10-Day Moving Average 249.95
Average True Range 5.4298
ADX 21.58
+DI 21.3461
-DI 27.6406
Chandelier Exit (Long, 3 ATRs ) 241.7706
Chandelier Exit (Short, 3 ATRs ) 245.2894
Upper Bollinger Band 259.7531
Lower Bollinger Band 239.7719
Percent B (%b) 0.43
BandWidth 8.00008
MACD Line 0.2811
MACD Signal Line 0.0894
MACD Histogram 0.1917
Fundamentals Value
Market Cap 56.51 Billion
Num Shares 228 Million
EPS 3.45
Price-to-Earnings (P/E) Ratio 71.97
Price-to-Sales 3.93
Price-to-Book 3.79
PEG Ratio 2.05
Dividend 2.92
Dividend Yield 1.18%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 261.17
Resistance 3 (R3) 262.24 259.02 259.02
Resistance 2 (R2) 259.02 255.75 258.49 258.31
Resistance 1 (R1) 253.67 253.73 252.06 252.60 257.59
Pivot Point 250.45 250.45 249.65 249.92 250.45
Support 1 (S1) 245.10 247.18 243.49 244.03 239.03
Support 2 (S2) 241.88 245.16 241.35 238.31
Support 3 (S3) 236.53 241.88 237.60
Support 4 (S4) 235.46